BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

704 related articles for article (PubMed ID: 24154729)

  • 1. Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis.
    Donadini MP; Ageno W; Antonucci E; Cosmi B; Kovacs MJ; Le Gal G; Ockelford P; Poli D; Prandoni P; Rodger M; Saccullo G; Siragusa S; Young L; Bonzini M; Caprioli M; Dentali F; Iorio A; Douketis JD
    Thromb Haemost; 2014 Jan; 111(1):172-9. PubMed ID: 24154729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis.
    Carrier M; Rodger MA; Wells PS; Righini M; LE Gal G
    J Thromb Haemost; 2011 Jun; 9(6):1119-25. PubMed ID: 21382171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-dimer and residual vein obstruction as risk factors for recurrence during and after anticoagulation withdrawal in patients with a first episode of provoked deep-vein thrombosis.
    Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
    Thromb Haemost; 2011 May; 105(5):837-45. PubMed ID: 21359409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Residual venous obstruction in patients with a single episode of deep vein thrombosis and in patients with recurrent deep vein thrombosis.
    Galli M; Ageno W; Squizzato A; Dentali F; Manfredi E; Steidl L; Venco A
    Thromb Haemost; 2005 Jul; 94(1):93-5. PubMed ID: 16113790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with a first symptomatic unprovoked deep vein thrombosis are at higher risk of recurrent venous thromboembolism than patients with a first unprovoked pulmonary embolism.
    Kovacs MJ; Kahn SR; Wells PS; Anderson DA; Chagnon I; LE Gal G; Solymoss S; Crowther M; Perrier A; Ramsay T; Betancourt MT; White RH; Vickars L; Rodger MA
    J Thromb Haemost; 2010 Sep; 8(9):1926-32. PubMed ID: 20561184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis.
    Cosmi B; Legnani C; Cini M; Guazzaloca G; Palareti G
    Thromb Haemost; 2005 Nov; 94(5):969-74. PubMed ID: 16363238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual venous obstruction, alone and in combination with D-dimer, as a risk factor for recurrence after anticoagulation withdrawal following a first idiopathic deep vein thrombosis in the prolong study.
    Cosmi B; Legnani C; Iorio A; Pengo V; Ghirarduzzi A; Testa S; Poli D; Tripodi A; Palareti G;
    Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):356-65. PubMed ID: 20034816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duplex imaging of residual venous obstruction to guide duration of therapy for lower extremity deep venous thrombosis.
    Stephenson EJ; Liem TK
    J Vasc Surg Venous Lymphat Disord; 2015 Jul; 3(3):326-32. PubMed ID: 26992315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis.
    Dentali F; Di Minno MN; Turato S; Crestani S; Ambrosino P; Bonfanti C; Di Minno G; Ageno W; Franchini M
    Thromb Res; 2014 Aug; 134(2):264-7. PubMed ID: 24882273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study.
    LE Gal G; Carrier M; Kovacs MJ; Betancourt MT; Kahn SR; Wells PS; Anderson DA; Chagnon I; Solymoss S; Crowther M; Righini M; Delluc A; White RH; Vickars L; Rodger M
    J Thromb Haemost; 2011 Jun; 9(6):1126-32. PubMed ID: 21324057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
    Marik PE; Cavallazzi R
    PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer.
    Dentali F; Barco S; Pegoraro S; Di Minno MND; Mastroiacovo D; Pomero F; Lodigiani C; Bagna F; Sartori M; Barillari G; Mumoli N; Napolitano M; Passamonti SM; Benedetti R; Ageno W; Di Nisio M
    J Thromb Thrombolysis; 2018 Oct; 46(3):404-408. PubMed ID: 30014299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.
    Prandoni P; Vedovetto V; Ciammaichella M; Bucherini E; Corradini S; Enea I; Cosmi B; Mumoli N; Visonà A; Barillari G; Bova C; Quintavalla R; Zanatta N; Pedrini S; Villalta S; Camporese G; Testa S; Parisi R; Becattini C; Cuppini S; Pengo V; Palareti G;
    Thromb Res; 2017 Jun; 154():35-41. PubMed ID: 28407492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
    Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
    Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term recurrence risk of patients with unprovoked venous thromboembolism: an observational cohort study.
    Kyrle PA; Kammer M; Eischer L; Weltermann A; Minar E; Hirschl M; Heinze G; Eichinger S
    J Thromb Haemost; 2016 Dec; 14(12):2402-2409. PubMed ID: 27696701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
    BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of recurrent venous thromboembolism in patients with unprovoked symptomatic deep vein thrombosis and asymptomatic pulmonary embolism.
    Jiménez D; Díaz G; Marín E; Vidal R; Sueiro A; Yusen RD
    Thromb Haemost; 2006 Mar; 95(3):562-6. PubMed ID: 16525588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
    Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
    Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.
    Prandoni P; Noventa F; Ghirarduzzi A; Pengo V; Bernardi E; Pesavento R; Iotti M; Tormene D; Simioni P; Pagnan A
    Haematologica; 2007 Feb; 92(2):199-205. PubMed ID: 17296569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.